CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $73,265
- in 1 filing
Net −$73,265. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-05 | ARMEN GARO H Director | Sale | −100,000 | $0.95 | $95K | 1,866,400 |
| 2023-05-05 | AGENUS INC 10% owner | Purchase | +100,000 | $0.95 | $95K | 21,594,847 |
| 2023-05-05 | AGENUS INC 10% owner | Purchase | +200 | $1.25 | $250 | 21,595,047 |
| 2023-05-04 | AGENUS INC 10% owner | Purchase | +21,473 | $1.22 | $26K | 21,494,847 |
| 2023-05-03 | AGENUS INC 10% owner | Purchase | +128,689 | $1.08 | $139K | 21,473,374 |
| 2023-05-01 | AGENUS INC 10% owner | Other disposition | −5,006,397 | 21,326,369 |
Page 7 of 7 · 126 trades